Gilder Gagnon Howe & Co’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-303,642
| Closed | -$3.83M | – | 248 |
|
|
2022
Q3 | $3.83M | Sell |
303,642
-1,515
| -0.5% | -$19.1K | 0.07% | 147 |
|
|
2022
Q2 | $3.23M | Sell |
305,157
-33,852
| -10% | -$358K | 0.06% | 158 |
|
|
2022
Q1 | $5.51M | Sell |
339,009
-1,770
| -0.5% | -$28.8K | 0.05% | 172 |
|
|
2021
Q4 | $4.72M | Buy |
340,779
+26,973
| +9% | +$374K | 0.03% | 221 |
|
|
2021
Q3 | $4.51M | Buy |
313,806
+413
| +0.1% | +$5.93K | 0.02% | 258 |
|
|
2021
Q2 | $4.96M | Buy |
313,393
+101,986
| +48% | +$1.61M | 0.02% | 259 |
|
|
2021
Q1 | $2.15M | Buy |
+211,407
| New | +$2.15M | 0.01% | 276 |
|
|
2020
Q4 | – | Sell |
-592,200
| Closed | -$2.03M | – | 339 |
|
|
2020
Q3 | $2.03M | Buy |
+592,200
| New | +$2.03M | 0.01% | 237 |
|